Literature DB >> 9133499

Cardiac autoantibodies in dilated cardiomyopathy: a pathogenetic role?

C J Limas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9133499     DOI： 10.1161/01.cir.95.8.1979

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

2.  Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy.

Authors:  N de Leeuw; W J Melchers; D J Ruiter; A L Caforio; A H Balk; N de Jonge; J M Galama
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

3.  Lack of effects of recombinant human growth hormone in a child with a complex cardiovascular malformation and dilated cardiomyopathy.

Authors:  L Rosti; E Cerini; P Festa; A Miola; V Brunelli; A Frigiola
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

4.  Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

Authors:  Roland Jahns; Valérie Boivin; Lutz Hein; Sven Triebel; Christiane E Angermann; Georg Ertl; Martin J Lohse
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

5.  Antibodies to cardiac receptors.

Authors:  V Boivin-Jahns; A Schlipp; S Hartmann; P Panjwani; K Klingel; M J Lohse; G Ertl; R Jahns
Journal:  Herz       Date:  2012-12       Impact factor: 1.443
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.